FDA Inspection 1325138 — Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)
The FDA completed an inspection of Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) on Jun 26, 2026 in Shenzhen. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 26, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shenzhen (China)